AJANTA PHARMA
|
|
BOM : 532331     NSE : AJANTPHARM     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward Pledged Shares : None or < 25% |
Aug 18,2022 |
Price(EOD): ₹ 1,258.65
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 16,123.31 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
AJANTA PHARMA | -1% | 1.9% | -14.9% |
SUN PHARMACEUTICAL INDUSTRIES | -0.5% | 3.7% | 18.3% |
DIVIS LABORATORIES | -5.2% | 0.2% | -23.8% |
DR REDDYS LABORATORIES | -0.7% | -5.4% | -9% |
CIPLA | -0.6% | 6.8% | 14.7% |
GLAND PHARMA | 2.2% | -2.6% | -44.7% |
PIRAMAL ENTERPRISES | 2.9% | 15.5% | -27.5% |
CADILA HEALTHCARE | 3.2% | 10% | -28.4% |
TORRENT PHARMACEUTICALS | 1.6% | 3.6% | 5.1% |
FUNDAMENTAL ANALYSIS OF AJANTA PHARMA
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF AJANTA PHARMA
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
15.08
P/E Calculated based on EPS of 83.45
[ Mar2022 - Consolidated Results ] 3.29
P/B Calculated based on Book Value of 382.2
[ Mar2022 - Consolidated Results ] 4.55
P/S Calculated based on Revenues of 3543.93 Cr
[ TTM - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
62% 88% 100% |
SHARE PRICE MOMENTUM OF AJANTA PHARMA
AJANTA PHARMA vs SENSEX
DEBT OF AJANTA PHARMA
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0 0 0 - |
0 0 0.02 0.01 |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF AJANTA PHARMA
Pledged Promoter Shares |
20.09 % | |
---|---|---|
As on : Jun2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF AJANTA PHARMA
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
9.27% 7.29% 12.24% 15.48% |
27.13% 0.7% 0.64% 0.5% |
QtrlyTrend |
8 | |
Latest Qtr: Jun2022 | ||
Quarterly Result Analysis → |
AJANTA PHARMA related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE 150 MIDCAP | 3.2% | 11.9% | 11.7% |
S&P BSE 400 MIDSMALLCAP | 2.8% | 11.3% | 9.8% |
S&P BSE 250 LARGEMIDCAP | 2.7% | 12.5% | 11.4% |
S&P BSE LARGE MIDCAP | 2.7% | 12.5% | 11.3% |
S&P BSE 500 | 2.7% | 12.3% | 11% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY MIDCAP150 | 3% | 12.4% | 14.5% |
NIFTY MIDCAP150 QUALITY 50 | 2.9% | 12.1% | 5.2% |
NIFTY LARGE MIDCAP 250 | 2.8% | 12.5% | 12.6% |
NIFTY MID SMALL400 | 2.7% | 11.4% | 11.5% |
NIFTY 500 | 2.6% | 12.2% | 10.8% |
You may also like the below Video Courses
FAQ about AJANTA PHARMA
Is AJANTA PHARMA good for long term investment?
As on Aug 18,2022, the Fundamentals of AJANTA PHARMA look Strong and hence it may be good for long term investment! See Financial Performance of AJANTA PHARMA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is AJANTA PHARMA UnderValued or OverValued?
As on Aug 18,2022, AJANTA PHARMA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of AJANTA PHARMA ?
As on Aug 18,2022, the Intrinsic Value of AJANTA PHARMA is Rs. 668.12 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 778.13
Fair Value [Median EV / Sales Model] : Rs. 668.12
Fair Value [Median Price / Sales Model] : Rs. 628.00
Median Fair Value of AJANTA PHARMA : Rs. 668.12
Is AJANTA PHARMA trading at a Premium or Discount?
As on Aug 18,2022, AJANTA PHARMA is trading at a Premium of 88% based on the estimates of Median Intrinsic Value!SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
